MedTrace Logo

Use of Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin Damage

NCT04688749 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2023-07-25

No results posted yet for this study

Summary

The purpose of this clinical study is to evaluate if the DermaSense prototype EIS scanner can provide medical decision support which can complement dermoscopy-based identification of the disease at time of biopsy decision.

Conditions

Interventions

DIAGNOSTIC_TEST

Electrical Impedence Spectroscopy DermaSense

Two sets of measurements will be performed to each subject, either at a nevus in contrast with a nearby clear patch of skin. The duration of each measurement will last for approximately 1.5 minutes and the excel file will be directly available to researcher, allowing him/her for data storage and data visualization.

Sponsors & Collaborators

  • Aristotle University Of Thessaloniki

    lead OTHER

Principal Investigators

  • Emmanouil Papanastasiou, Dr. · Assistant Professor

Eligibility

Min Age
8 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-07-17
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04688749 on ClinicalTrials.gov